Acute pancreatitis
Disease7 papers5 findings
- Humans6
Associations
4Type 2 diabetes
upin humans1upin silico1
2 studies
Type 2 diabetes
upin humans1upin silico1
Acute pancreatitis raises the risk of type 2 diabetes in humans.
Humans13.7 years
Long-Term Multisystem Comorbidity Patterns in Acute Pancreatitis: Insights From Observational and Genetic Analysis · United European gastroenterology journal · 1 Sep 2026
Acute pancreatitis predicts type 2 diabetes in silico (AUROC 0.79).
In silicousing logistic regression machine learning model trained on EHR datan = 58,746
Machine learning models for predicting new-onset diabetes following acute pancreatitis using real-world data · BMJ public health · 25 Aug 2026
PhenoAgeAccel
upin humans1HR 1.637
1 study
PhenoAgeAccel
upin humans1HR 1.637
PhenoAgeAccel raises the risk of acute pancreatitis in humans (HR 1.637, 95% CI 1.352-1.981).
Humansfully adjusted Cox model, compared with G1
Biological aging, circulating lipid biomarkers and pancreatic diseases: a prospective cohort study based on the UK Biobank · The journal of nutrition, health & aging · 15 Sep 2026
Mortality
upin humans1
1 study
Mortality
upin humans1
Acute pancreatitis raises the risk of mortality in humans.
Humans13.7 years
Long-Term Multisystem Comorbidity Patterns in Acute Pancreatitis: Insights From Observational and Genetic Analysis · United European gastroenterology journal · 1 Sep 2026
GLP-1 receptor agonists
downin humans1HR 0.247Low certainty
1 study
GLP-1 receptor agonists
downin humans1HR 0.247Low certainty
GLP-1 receptor agonists lower the risk of acute pancreatitis in humans (HR 0.247, 95% CI 0.149-0.409).
Humansin non-diabetic adults with chronic pancreatitis
Clinical Outcomes Associated with GLP-1 Receptor Agonist Exposure in Non-Diabetic Patients with Chronic Pancreatitis: A Retrospective Cohort Study · Journal of personalized medicine · 20 Aug 2026
Trial sponsors
First Affiliated Hospital Xi'an Jiaotong University
1 trialPhase 42,700 people
Peking Union Medical College Hospital
1 trialPhase 4220 people
First Affiliated Hospital of Wenzhou Medical University
1 trialPhase 4200 people
University Medical Centre Ljubljana
1 trialPhase 430 people
The First Affiliated Hospital of Nanchang University
2 trialsPhase 2120 people
1 trialPhase 250 people
1 trialPhase 28 people
First Affiliated Hospital of Chengdu Medical College
1 trialPhase 1/280 people
Funding
National Institute of Diabetes and Digestive and Kidney DiseasesUS$655.3k2 grants since 2020
University of Minnesota Clinical Center for the Study of Acute Pancreatitis and Diabetes
National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of MinnesotaUS$492.8k2020–2030
Dietary Predictors of New-Onset Diabetes following Acute Pancreatitis in the DREAM Study.
National Institute of Diabetes and Digestive and Kidney DiseasesPennsylvania State Univ Hershey Med CtrUS$162.5k2024–2028